Myeloma Paper of the Day, July 22nd, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Study examining survival among myeloma patients in the United States Military Health System versus the Surveillance, Epidemiology, and End Results (SEER) Program finds former do better (median OS 47.1 months vs. 33.0 months).”
Source: Robert Orlowski/X
Authors: Alexander Dew, Jie Lin, Sarah Darmon, Joe Roswarski, Craig Shriver, Kangmin Zhu, and Alden Chiu.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023